Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
American Urological Association Releases Male Infertility Guideline Amendment
BALTIMORE, Aug 15, 2024 (GLOBE NEWSWIRE) -- Today, the American Urological Association (AUA), in partnership with the American Society for Reproductive Medicine (ASRM), released the 2024 amendment to the Male Infertility Guideline.
The purpose of this Guideline is to outline the appropriate evaluation and management of the male partner in an infertile couple. Recommendations proceed from obtaining an appropriate history and physical exam, as well as diagnostic testing, where indicated. Medical therapies, surgical techniques, and use of IUI and ART are covered to allow for optimal patient management. The 2024 amendment has introduced new evidence to support updated information on the evaluation and management of male infertility.
“We are excited to share this updated version of the Male Infertility Guideline. This amendment builds on the outstanding, inaugural version of the Male Infertility Guideline that was published in 2021,” said Guideline Amendment Chair Dr. Robert E. Brannigan, Professor of Urology at Northwestern University, Feinberg School of Medicine. “The updated Guideline includes numerous new, important recommendations that will enhance the ability of urologists to provide optimal, state-of-the-art care for infertile males
This Guideline has 54 recommendations and serves as a useful reference on effective, evidence-based care as it relates to male infertility.
The Guideline amendment highlights the following:
- Update to a recommendation on evaluating azoospermic patients
- Update to a recommendation on karyotype testing
- Updates on which imaging modalities should or should not be used when evaluating patients
- A new recommendation on utilization of testicular sperm in nonazoospermic patients
- Updates to the WHO reference ranges for human semen characteristics
- A new table defining common terms in semen analysis
“Male infertility contributes to 50% of cases and also provides a window into male general health,” said Paula Amato, MD, ASRM President. “These guidelines will assist health care providers with the evaluation and management of male infertility, leading to improved male reproductive potential, offspring health and men's general health.”
The full Guideline is now available at: auanet.org/MaleInfertilityGuideline2024
A summary of the Guideline also appears at:
Brannigan RE, Hermanson L, Kaczmarek J, Kim SK, Kirkby E, Tanrikut C. Updates to male infertility: AUA/ASRM guideline (2024). J Urol. Published online August 15, 2024. doi:10.1097/JU.0000000000004180
https://www.auajournals.org/doi/10.1097/JU.0000000000004180
About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 23,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.
Contact:
Corey Del Bianco, Corporate Communications & Media Relations Manager
443-909-4033,
cdelbianco@AUAnet.org
SOURCE American Urological Association